Autonomize

Austin, United States Founded: 2021 • Age: 5 yrs
AI software for drug discovery and trial management is offered.
Request Access

About Autonomize

Autonomize is a company based in Austin (United States) founded in 2021 by Ganesh Padmanabhan and Kris Nair.. Autonomize has raised $32.02 million across 2 funding rounds from investors including Valtruis, Next Practices Group and Asset Management Ventures. Autonomize offers products and services including Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing. Autonomize operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.

  • Headquarter Austin, United States
  • Founders Ganesh Padmanabhan, Kris Nair
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Autonomize Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $32.02 M (USD)

    in 2 rounds

  • Latest Funding Round
    $28 M (USD), Series A

    May 28, 2025

  • Investors
    Valtruis

    & 7 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Autonomize

Autonomize offers a comprehensive portfolio of products and services, including Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Automates extraction and summarization of authorization requests for faster decisions.

Identifies and addresses care gaps using patient data for better outcomes.

Transforms unstructured medical data into structured insights for decision-making.

Compiles case summaries from various sources to support informed patient care.

Structures and summarizes documents like contracts for actionable workflows.

People of Autonomize
Headcount 10-50
Employee Profiles 21
Employee Profiles
People
Kaavya R
Director Of Engineering And Qa
People
Harshita Garg
Senior Software Engineer
People
Surya Sandeep Boda
Software Engineering Manager
People
Adharsh C
Junior Data Scientist

Unlock access to complete

Funding Insights of Autonomize

Autonomize has successfully raised a total of $32.02M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $28 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $28.0M
  • First Round

    (10 Apr 2023)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2025 Amount Series A - Autonomize Valuation Valtruis , Cigna Ventures
Apr, 2023 Amount Seed - Autonomize Valuation Asset Management Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Autonomize

Autonomize has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Valtruis, Next Practices Group and Asset Management Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage US companies are invested in by Asset Management Ventures.
Founded Year Domain Location
Early-stage venture capital investments are made by ATX Venture Partners.
Founded Year Domain Location
Loop Ventures is involved in venture capital activities.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Autonomize

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Autonomize

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Autonomize Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Autonomize

Autonomize operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
domain founded_year HQ Location
AI-based solutions for health management are provided.
domain founded_year HQ Location
Clinical trial management software is provided for researchers and professionals.
domain founded_year HQ Location
Signant Health is engaged in providing clinical trial technology solutions.
domain founded_year HQ Location
Regulatory and ethical review services for clinical research are provided.
domain founded_year HQ Location
AI enabled solutions for clinical trials
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Autonomize

Frequently Asked Questions about Autonomize

When was Autonomize founded?

Autonomize was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Autonomize located?

Autonomize is headquartered in Austin, United States. It is registered at Austin, Texas, United States.

Is Autonomize a funded company?

Autonomize is a funded company, having raised a total of $32.02M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.02M, raised on Apr 10, 2023.

What does Autonomize do?

Autonomize was founded in 2021 and is based in Austin, United States. Operations focus on the biotechnology sector, where AI-driven software is provided to researchers for drug targeting, toxicity assessment, and clinical trial management. Features include handling of biomedical and clinical data, along with workflow tools to support research processes. The platform aids in streamlining drug development activities.

Who are the top competitors of Autonomize?

Autonomize's top competitors include Medidata, Verily and Deep 6 AI.

What products or services does Autonomize offer?

Autonomize offers Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing.

Who are Autonomize's investors?

Autonomize has 8 investors. Key investors include Valtruis, Next Practices Group, Asset Management Ventures, ATX Venture Partners, and Loop Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available